MidWest Drug Development Conference
ONLINE EVENT | Oct. 4-5, 2021
2021-10-04 08:00:00
Register!
Downloads
  • 2021 Program
  • Flyer
  • 2021 Schedule
  • 2019 Program
  • 2018 Program
  • Map & Other Info (Coming soon!)
  • Home
  • Schedule
  • Venue
  • Technologies
    • Categories
    • Institutions
    • Startups
    • Previous Technologies
  • Sponsors
  • News
  • Contact
  • Home
  • Schedule
  • Venue
  • Technologies
    • Categories
    • Institutions
    • Startups
    • Previous Technologies
  • Sponsors
  • News
  • Contact

Engineered bacterial strain eliminates drug resistance in GI tract

Medical College of Wisconsin

Medical College of Wisconsin inventors have developed a novel biotherapeutic for eliminating antibiotic-resistant enterococci from the GI tract. The engineered Enterococcus faecalis (EF) specifically targets enterococci in the gut while leaving beneficial commensal bacteria alone. Additionally, the engineered EF cannot stably colonize the gut, making it amenable as a dosed therapeutic.

Vancomycin-resistant enterococci (VRE) is a major type of hospital acquired infections worldwide. In addition to vancomycin, VRE are increasingly resistant to other antibiotics, significantly reducing treatment options for vulnerable, hospitalized patients. Pathogenic enterococci can also cause several diseases in farm animals such as poultry and dairy cattle.

This novel biotherapeutic EF is engineered to combat antibiotic resistant and pathogenic enterococci by exploiting antimicrobial bacteriocins.

This engineered Enterococci has the potential to be an effective therapeutic against antibiotic resistance enterococci , such as VRE, and other pathogenic enterococci in humans and animals.

Key Advantages

  • Antibiotic-free method of eliminating Enterococci
  • Does not affect beneficial bacteria in gut; Enterococci specific
  • Therapeutic profile due to inability to establish stable colony

Logo

MIDWEST DRUG DEVELOPMENT CONFERENCE
Bringing together industry and the best university drug development researchers in the Midwest
An Online Event
Oct. 4-5, 2021

Latest News
  • Presentation schedule set for 2021 September 21, 2021
  • MWDD moves to a virtual event in 2021 August 17, 2021
  • Sponsorship, presentation slots nearly full July 29, 2021
  • Registrations are now open for 2021 March 25, 2021
Twitter Hightlights
  • Today's the day!
    491 days ago
  • Schedule is set for the 2021 MidWest Drug Development Conference. Register today! https://t.co/5SvzL4EhuV
    504 days ago
  • No surprise to see some incredible innovations out of @UWMadison that could change drug delivery approaches, cancer… https://t.co/h90yfHwC5k
    505 days ago

Follow us! @DrugMw